BB
Bullseye Biodevices, Inc.
SEC filingBiotechnology · Hoboken, NJ
Amount raised$1.3Msold at filing
Total offering$1.3M
Investors in the raise1count reported to the SEC
FiledAug 10, 2026first sale Jul 28, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Jinho KimExecutive Officer, Director
Mohammad MirExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.